These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15383159)

  • 1. Buspirone to improve compliance in venlafaxine-induced movement disorder.
    Pavlovic ZM
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):523-4. PubMed ID: 15383159
    [No Abstract]   [Full Text] [Related]  

  • 2. Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.
    Kuloglu M; Ekinci O; Caykoylu A
    J Psychopharmacol; 2010 Apr; 24(4):627-8. PubMed ID: 19264817
    [No Abstract]   [Full Text] [Related]  

  • 3. Buspirone as an antidote to venlafaxine-induced bruxism.
    Jaffee MS; Bostwick JM
    Psychosomatics; 2000; 41(6):535-6. PubMed ID: 11110119
    [No Abstract]   [Full Text] [Related]  

  • 4. Venlafaxine-induced galactorrhea.
    Sternbach H
    J Clin Psychopharmacol; 2003 Feb; 23(1):109-10. PubMed ID: 12544389
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine plus venlafaxine in treatment-resistant depression.
    Devarajan S; Dursun SM
    J Psychopharmacol; 2005 Jul; 19(4):434-5. PubMed ID: 15983004
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 7. Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.
    Liau CH; Shen WW; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):121-2. PubMed ID: 16472373
    [No Abstract]   [Full Text] [Related]  

  • 8. Venlafaxine and the rapid development of anasarca.
    Ballon JS; Schulman MC
    J Clin Psychopharmacol; 2006 Feb; 26(1):97-8. PubMed ID: 16415719
    [No Abstract]   [Full Text] [Related]  

  • 9. Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.
    Luborzewski A; Regen F; Schindler F; Anghelescu I
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):248-9. PubMed ID: 16720809
    [No Abstract]   [Full Text] [Related]  

  • 10. Venlafaxine withdrawal syndrome: report of seven cases in Trinidad.
    Baboolal NS
    J Clin Psychopharmacol; 2004 Apr; 24(2):229-31. PubMed ID: 15206672
    [No Abstract]   [Full Text] [Related]  

  • 11. Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine.
    Vaccaro M; Borgia F; Barbuzza O; Guarneri B
    Br J Dermatol; 2007 Oct; 157(4):822-4. PubMed ID: 17655739
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.
    Dallal A; Chouinard G
    J Clin Psychopharmacol; 1998 Aug; 18(4):343-4. PubMed ID: 9690703
    [No Abstract]   [Full Text] [Related]  

  • 13. An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms.
    Reznik I; Rosen Y; Rosen B
    J Psychopharmacol; 1999; 13(2):193-5. PubMed ID: 10475726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.
    Chial HJ; Camilleri M; Ferber I; Delgado-Aros S; Burton D; McKinzie S; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2003 May; 1(3):211-8. PubMed ID: 15017493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute cytolytic hepatitis after taking venlafaxine].
    Maroy B
    Gastroenterol Clin Biol; 2002; 26(8-9):804. PubMed ID: 12434090
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
    Benazzi F
    Can J Psychiatry; 1997 Nov; 42(9):980-1. PubMed ID: 9429070
    [No Abstract]   [Full Text] [Related]  

  • 17. Venlafaxine-related akathisia side-effects and management in a depressed patient.
    Lai CH
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):127-8. PubMed ID: 23438168
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated defibrillation threshold with venlafaxine therapy.
    Carnes CA; Pickworth KK; Votolato NA; Raman SV
    Pharmacotherapy; 2004 Aug; 24(8):1095-8. PubMed ID: 15338858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mania associated with venlafaxine discontinuation.
    Fava GA; Mangelli L
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):89-90. PubMed ID: 12899740
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective treatment of venlafaxine-induced noncyclical mastalgia with bromocriptine.
    Bhatia SC; Bhatia SK; Bencomo L
    J Clin Psychopharmacol; 2000 Oct; 20(5):590-1. PubMed ID: 11001253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.